ROSATOM to supply Brazil with promising isotopes needed in Nuclear Medicine
Isotope JSC (a part of Rusatom Healthcare JSC, Rosatom’s radiation technologies integrator) has signed a five-year contract with Brazil’s Nuclear and Energy Research Institute (IPEN; linked to the National Nuclear Energy Commission or CNEN) to supply lutetium-177 and actinium-225, the most promising medical isotopes in Radiopharma.
Rosatom facility gains record revenues from stable isotopes sales
In 2020, revenue from sales of stable isotopes manufactured by Electrochemical Plant JSC (an enterprise of ROSATOM’s TVEL Fuel Company in Zelenogorsk, Krasnoyarsk region) increased by 14% year on year, exceeding 1.5 billion rubles for the first time.
ROSATOM and Apulia continue cooperation by testing lutetium-177 used in cancer treatment
Isotope JSC, official distributor of isotope products manufactured by ROSATOM’s enterprises, successfully delivered lutetium-177 produced according to EU GMP standards to Nuclear Medicine Department of Policlinico of Bari (Apulia, Italy) for quality evaluation. The activity was implemented within the scope of the Healthcare Memorandum of Understanding signed between Apulia Region and ROSATOM in November 2019.
Isotope JSC at EANM Virtual Congress
Come to see us at our virtual booth!
ROSATOM at the 34th Brazilian Congress of Nuclear Medicine (CBMN)
Rio de Janeiro, September 8. ROSATOM took part in the 34th Annual Brazilian Congress of Nuclear Medicine, a key event in the country's nuclear medicine which closed Monday, September 7.
ROSATOM Moves to United Brand
August 20, Moscow - ROSATOM has switched to using a united brand. While preserving their names and unique identity, organizations of the Russian nuclear industry will get unified logos based on the trademark of ROSATOM - the Mobius strip. Such approach to corporate branding is called “umbrella branding,” and many top-class global corporations are using it.
Roberto La Forgia: «For true scientists or doctors, patients are beyond nationality»
In 2018, an Italian, Roberto La Forgia came to work in Russia joining JSC Isotope team to become the only foreigner in ROSATOM’s nuclear medicine business.
Maxim Kushnarev is appointed General Director of JSC Isotope
On February 20th, 2020, Kushnarev Maxim Sergeevich was appointed to the position of JSC Isotope General Director.
JSC Isotope presented products at isotope conference held in Malaysia
During the 10th International Conference on Isotopes (hereinafter - 10ICI), held in Kuala Lumpur (Malaysia) from 3 to 7 of February, 2020, JSC Isotope presented products manufactured by Rosatom State Corporation isotope complex enterprises.
ROSATOM signed a memorandum of understanding in the healthcare field with the Apulia region of Italy
On November, 13, Rusatom Healthcare (ROSATOM industry integrator in the field of radiation technologies in medicine and industry) Director General Aleksandr Shibanov, president of the region Apulia (Republic of Italy) Michele Emiliano, representatives of Sechenov University (Moscow) and Bari University, as well as JSC Isotope signed a memorandum of understanding in order to develop and strengthen cooperation in the field of healthcare, therapeutic radiology in oncology and nuclear medicine in the Russian Federation and the Apulia region.